PubRank

Clara Lehmann

Author PubWeight™ 16.77‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide: a randomized controlled trial. JAMA 2007 2.70
2 Broad neutralization by a combination of antibodies recognizing the CD4 binding site and a new conformational epitope on the HIV-1 envelope protein. J Exp Med 2012 2.12
3 Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease. J Virol 2010 1.61
4 Relevance of the organic cation transporters 1 and 2 for antiretroviral drug therapy in human immunodeficiency virus infection. Drug Metab Dispos 2008 1.12
5 Short-course antiretroviral therapy in primary HIV infection. N Engl J Med 2013 1.08
6 HIV replication alters the composition of extrinsic pathway coagulation factors and increases thrombin generation. J Am Heart Assoc 2013 1.04
7 Decreased frequency of CD73+CD8+ T cells of HIV-infected patients correlates with immune activation and T cell exhaustion. J Leukoc Biol 2013 0.91
8 Fatal cerebral lymphomatoid granulomatosis in an HIV-1-infected patient. J Infect 2006 0.90
9 An open-label pilot study of the efficacy and safety of anakinra in patients with psoriatic arthritis refractory to or intolerant of methotrexate (MTX). Clin Rheumatol 2010 0.90
10 CCR5 antibodies HGS004 and HGS101 preferentially inhibit drug-bound CCR5 infection and restore drug sensitivity of Maraviroc-resistant HIV-1 in primary cells. Virology 2011 0.86
11 Sex differences in immune responses to infectious diseases. Infection 2015 0.84
12 Vγ2Vδ2 T cells are skewed toward a terminal differentiation phenotype in untreated HIV infection. J Infect Dis 2013 0.84
13 Sensitive assessment of the virologic outcomes of stopping and restarting non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy. PLoS One 2013 0.84
14 Higher rates of AIDS during the first year of antiretroviral therapy among migrants: the importance of tuberculosis. AIDS 2013 0.83
15 Vicriviroc: a CCR5 antagonist for treatment-experienced patients with HIV-1 infection. Expert Opin Investig Drugs 2009 0.77
16 Corrigendum: Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117. Nature 2016 0.75